Integra Lifesciences Holdings Corp · Stock-Based Compensation

Latest reported$11.42Mperiod endingJun 30, 2026

IART Stock-Based Comp ($0.00 → $11.42M)

Annual stock-based compensation

High-resolution chart · PNG

IART stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Integra Lifesciences Holdings Corp Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	18,583,000
Dec 31, 2024	24,377,000
Dec 31, 2023	20,143,000
Dec 31, 2022	27,725,000
Dec 31, 2021	36,210,000
Dec 31, 2020	19,590,000
Dec 31, 2019	21,255,000
Dec 31, 2018	20,779,000
Dec 31, 2017	21,550,000
Dec 31, 2016	17,310,000
Dec 31, 2015	15,450,000
Dec 31, 2014	15,105,000
Dec 31, 2013	10,393,000
Dec 31, 2012	9,051,000
Dec 31, 2011	26,805,000
Dec 31, 2010	17,209,000
Dec 31, 2009	15,580,000
Dec 31, 2008	-1,224,000
Dec 31, 2007	-1,224,000
Dec 31, 2006	-1,335,000
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0